Pacira BioSciences, Inc.
NASDAQ:PCRX · NASDAQ Global Select
-$0.18 today
Vol 0.76M · Avg 0.57M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-9.74%
Period High
$27.22
Period Low
$19.16
Latest
$22.33
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
AnaptysBio, Inc.
NASDAQ:ANAB
$2.40B
Kodiak Sciences Inc.
NASDAQ:KOD
$1.88B
UroGen Pharma Ltd.
NASDAQ:URGN
$1.58B
Mind Medicine (MindMed) Inc.
MNMD
$1.56B
Tandem Diabetes Care, Inc.
NASDAQ:TNDM
$1.07B
Cronos Group Inc.
NASDAQ:CRON
$991.06M
Xencor, Inc.
NASDAQ:XNCR
$938.88M
Phathom Pharmaceuticals, Inc.
NASDAQ:PHAT
$855.87M
Oculis Holding AG
NASDAQ:OCS
$629.04M
BridgeBio Oncology Therapeutics Inc.
NASDAQ:BBOT
$607.61M
What is the latest PCRX filing?
The latest filing shown is 4 dated Jun 12, 2026.
How many recent filings does PCRX have?
Intrinsic Alpha currently shows 20 recent filings for PCRX.
Explore More
Continue the stock analysis
Jump to another research area for this company.